About 50% of MMTV-Wnt-1 transgenic female mice develop mammary tumors by 5–6 months of age [15], and these mice have therefore frequently been used to study the effect of potential tumor suppressor or oncogenes on mammary gland tumorigenesis (for review, see [16]). The gene discussed is WNT1; the disease is neoplasm.